Bottom line
SWHFX vs HCPIX: the short answer
SWHFX (Schwab Health Care Fund) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 61% by weight.
SWHFX is cheaper at 0.8% vs 1.76% — a difference of $96 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +6.4% for HCPIX (reporting dates differ).
Updated Nov 19, 2026
SWHFX vs HCPIX side by side
| SWHFX | HCPIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Schwab | ProShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 1.76% |
| Annual cost per $10k | $80 | $176 |
| 10-yr cost on $10k (prospectus) | $990 | $2,073 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +15.9% | −1.4% |
| 5-yr return (annualized) | +6.5% | +6.4% |
| 10-yr return (annualized) | +8.1% | +9.2% |
| Best quarter | +15.3% | +22.0% |
| Worst quarter | −12.1% | −21.0% |
| Net assets (fund) | $642.3M | $12.1M |
| Number of holdings | 80 | 69 |
| Portfolio turnover | 41% | 99% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWHFX | HCPIX | Difference |
|---|---|---|---|
| 2024 | +0.1% | −1.4% | +1.5% |
| 2023 | +0.7% | −1.3% | +2.0% |
| 2022 | −4.7% | −10.6% | +5.9% |
| 2021 | +23.3% | +33.9% | −10.6% |
| 2020 | +12.9% | +16.9% | −4.0% |
| 2019 | +17.6% | +28.4% | −10.8% |
| 2018 | +4.0% | +5.0% | −1.0% |
| 2017 | +20.2% | +32.2% | −12.0% |
| 2016 | −4.4% | −6.5% | +2.2% |
Source: Fund prospectus bar charts
Holdings overlap
14 of SWHFX's top 25 holdings also appear in HCPIX's top 25.
| Holding | SWHFX | HCPIX |
|---|---|---|
| Eli Lilly & Co | 13.92% | 11.83% |
| Johnson & Johnson | 6.94% | 8.03% |
| AbbVie Inc | 5.81% | 5.77% |
| Merck & Co Inc | 4.98% | 4.19% |
| UnitedHealth Group Inc | 4.74% | 4.90% |
| Gilead Sciences Inc | 3.24% | 2.10% |
| Amgen Inc | 2.58% | 2.71% |
| Bristol-Myers Squibb Co | 2.44% | 1.74% |
| Thermo Fisher Scientific Inc | 2.16% | 2.78% |
| Stryker Corp | 2.11% | 1.46% |
| Vertex Pharmaceuticals Inc | 1.89% | 1.57% |
| Abbott Laboratories | 1.60% | 2.40% |
| Danaher Corp | 1.47% | 1.60% |
| Elevance Health Inc | 1.45% | 1.06% |
Source: SEC Form N-PORT
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
HCPIX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
FAQ
What is the difference between SWHFX and HCPIX?
Which is cheaper, SWHFX or HCPIX?
Should I own both SWHFX and HCPIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.